1
|
Fock KM and Ang TL: Epidemiology of
Helicobacter pylori infection and gastric cancer in Asia. J
Gastroenterol Hepatol. 25:479–486. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Plummer M, Franceschi S, Vignat J, Forman
D and de Martel C: Global burden of gastric cancer attributable to
Helicobacter pylori. Int J Cancer. 136:487–490. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wilkinson N: Management of gastric
cancerSurgical Oncology Clinics. Saunders; Philadelphia, PA: 2012,
View Article : Google Scholar : PubMed/NCBI
|
4
|
Abnet CC, Freedman ND, Hu N, Wang Z, Yu K,
Shu XO, Yuan JM, Zheng W, Dawsey SM, Dong LM, et al: A shared
susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma
and esophageal squamous cell carcinoma. Nat Genet. 42:764–767.
2010. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Gleeson CM, Sloan JM, McManus DT, Maxwell
P, Arthur K, McGuigan JA, Ritchie AJ and Russell SE: Comparison of
p53 and DNA content abnormalities in adenocarcinoma of the
oesophagus and gastric cardia. Br J Cancer. 77:277–286. 1998.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Kamangar F, Dawsey SM, Blaser MJ,
Perez-Perez GI, Pietinen P, Newschaffer CJ, Abnet CC, Albanes D,
Virtamo J and Taylor PR: Opposing risks of gastric cardia and
noncardia gastric adenocarcinomas associated with Helicobacter
pylori seropositivity. J Natl Cancer Inst. 98:1445–1452. 2006.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Kim MA, Lee HS, Yang HK and Kim WH:
Clinicopathologic and protein expression differences between cardia
carcinoma and noncardia carcinoma of the stomach. Cancer.
103:1439–1446. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ziogas D, Baltogiannis G, Fatouros M and
Roukos DH: Identifying and preventing high-risk gastric cancer
individuals with CDH1 mutations. Ann Surg. 247:714–715; author
reply 715–716. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Norton JA, Ham CM, Van Dam J, Jeffrey RB,
Longacre TA, Huntsman DG, Chun N, Kurian AW and Ford JM: CDH1
truncating mutations in the E-cadherin gene: An indication for
total gastrectomy to treat hereditary diffuse gastric cancer. Ann
Surg. 245:873–879. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yu J, Tao Q, Cheng YY, Lee KY, Ng SS,
Cheung KF, Tian L, Rha SY, Neumann U, Röcken C, et al: Promoter
methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is
associated with poor survival in gastric cancer. Cancer. 115:49–60.
2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lee HJ, Nam KT, Park HS, Kim MA, Lafleur
BJ, Aburatani H, Yang HK, Kim WH and Goldenring JR: Gene expression
profiling of metaplastic lineages identifies CDH17 as a prognostic
marker in early stage gastric cancer. Gastroenterology.
139:213–225. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Engelman JA, Zejnullahu K, Mitsudomi T,
Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen
J, et al: MET amplification leads to gefitinib resistance in lung
cancer by activating ERBB3 signaling. Science. 316:1039–1043. 2007.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen YR, Juan HF, Huang HC, Huang HH, Lee
YJ, Liao MY, Tseng CW, Lin LL, Chen JY, Wang MJ, et al:
Quantitative proteomic and genomic profiling reveals
metastasis-related protein expression patterns in gastric cancer
cells. J Proteome Res. 5:2727–2742. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chen CN, Lin JJ, Chen JJ, Lee PH, Yang CY,
Kuo ML, Chang KJ and Hsieh FJ: Gene expression profile predicts
patient survival of gastric cancer after surgical resection. J Clin
Oncol. 23:7286–7295. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wang G, Hu N, Yang HH, Wang L, Su H, Wang
C, Clifford R, Dawsey EM, Li JM, Ding T, et al: Comparison of
global gene expression of gastric cardia and noncardia cancers from
a high-risk population in China. PLoS One. 8:e638262013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article 3. 2004.PubMed/NCBI
|
18
|
Huang DW, Sherman BT, Tan Q, Collins JR,
Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki
RA: The DAVID gene functional classification tool: A novel
biological module-centric algorithm to functionally analyze large
gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Johnson AH, Frierson HF, Zaika A, Powell
SM, Roche J, Crowe S, Moskaluk CA and El-Rifai W: Expression of
tight-junction protein claudin-7 is an early event in gastric
tumorigenesis. Am J Pathol. 167:577–584. 2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zavala-Zendejas VE, Torres-Martinez AC,
Salas-Morales B, Fortoul TI, Montaño LF and Rendon-Huerta EP:
Claudin-6, 7, or 9 overexpression in the human gastric
adenocarcinoma cell line AGS increases its invasiveness, migration,
and proliferation rate. Cancer Invest. 29:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Zhang J, Liu QS and Dong WG: Blockade of
proliferation and migration of gastric cancer via targeting CDH17
with an artificial microRNA. Med Oncol. 28:494–501. 2011.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Lu P, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Stetler-Stevenson WG, Aznavoorian S and
Liotta LA: Tumor cell interactions with the extracellular matrix
during invasion and metastasis. Annu Rev Cell Biol. 9:541–573.
1993. View Article : Google Scholar : PubMed/NCBI
|
27
|
David L, Nesland JM, Holm R and
Sobrinho-Simões M: Expression of laminin, collagen IV, fibronectin,
and type IV collagenase in gastric carcinoma. An
immunohistochemical study of 87 patients. Cancer. 73:518–527. 1994.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Yang Z, Zhang X, Gang H, Li X, Li Z, Wang
T, Han J, Luo T, Wen F and Wu X: Up-regulation of gastric cancer
cell invasion by Twist is accompanied by N-cadherin and fibronectin
expression. Biochem Biophys Res Commun. 358:925–930. 2007.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Coe BP, Lee EH, Chi B, Girard L, Minna JD,
Gazdar AF, Lam S, MacAulay C and Lam WL: Gain of a region on
7p22.3, containing MAD1L1, is the most frequent event in small-cell
lung cancer cell lines. Genes Chromosomes Cancer. 45:11–19. 2006.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Guo Y, Zhang X, Yang M, Miao X, Shi Y, Yao
J, Tan W, Sun T, Zhao D, Yu D, et al: Functional evaluation of
missense variations in the human MAD1L1 and MAD2L1 genes and their
impact on susceptibility to lung cancer. J Med Genet. 47:616–622.
2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Begnami MD, Fregnani JH, Nonogaki S and
Soares FA: Evaluation of cell cycle protein expression in gastric
cancer: Cyclin B1 expression and its prognostic implication. Hum
Pathol. 41:1120–1127. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Al-azzeh ED, Fegert P, Blin N and Gött P:
Transcription factor GATA-6 activates expression of
gastroprotective trefoil genes TFF1 and TFF2. Biochim Biophys Acta.
1490:324–332. 2000. View Article : Google Scholar : PubMed/NCBI
|
33
|
Haveri H, Westerholm-Ormio M, Lindfors K,
Mäki M, Savilahti E, Andersson LC and Heikinheimo M: Transcription
factors GATA-4 and GATA-6 in normal and neoplastic human
gastrointestinal mucosa. BMC Gastroenterol. 8:92008. View Article : Google Scholar : PubMed/NCBI
|
34
|
Posey JT, Soloway MS, Ekici S, Sofer M,
Civantos F, Duncan RC and Lokeshwar VB: Evaluation of the
prognostic potential of hyaluronic acid and hyaluronidase (HYAL1)
for prostate cancer. Cancer Res. 63:2638–2644. 2003.PubMed/NCBI
|
35
|
Lokeshwar VB, Cerwinka WH, Isoyama T and
Lokeshwar BL: HYAL1 hyaluronidase in prostate cancer: A tumor
promoter and suppressor. Cancer Res. 65:7782–7789. 2005.PubMed/NCBI
|